|
Market Cap (19-May) $12,332,152 (1,885th) |
Close (15-Dec) $0.056 |
Volume (15-Dec) 0 |
Shortsold (8-Dec) 13,278 (0.02%) (428th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.024 |
CDY released this announcement to the ASX on 21 October 2020, 9:22. The announcement is not marked as price sensitive, and is 3 page(s) in length and 69.65kb in size.
You can view all announcements from CDY and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from CDY | |
|---|---|
| Results of Meeting | 9 December 2021, 13:11 |
| AGM Presentation to Shareholders | 9 December 2021, 11:03 |
| Release of Shares from Voluntary Escrow | 7 December 2021, 18:47 |
| Cellmid receives R&D tax credit | 10 November 2021, 9:38 |
| Proposed issue of securities - CDY | 9 November 2021, 16:48 |
| Letter to Shareholders - Notice of Annual General Meeting | 9 November 2021, 16:37 |
| Board Renewal To Align With Consumer Health Growth Strategy | 21 October 2020, 9:22 |
| There has been no announcements made to the ASX since this one. |
You must be logged in to post a reply.
Cellmid 